Gene: Kng1 (kininogen 1) Rattus norvegicus
Analyze
Symbol: Kng1
Name: kininogen 1
Description: Predicted to have cysteine-type endopeptidase inhibitor activity and signaling receptor binding activity; predicted to be involved in several processes, including acute-phase response, negative regulation of blood coagulation, and negative regulation of cell adhesion; predicted to localize to the cell and extracellular space; orthologous to human KNG1 (kininogen 1).
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: alpha-1-MAP; kininogen; kininogen 1-like 1; Kng1l1; low molecular weight (LMW) T-kininogen II; major acute phase protein (alpha-1-MAP); MGC108747; similar to alpha-1 major acute phase protein prepeptide; T-kininogen 2; T-kininogen II; thiostatin
Orthologs:
Mus musculus (house mouse) : Kng1 (kininogen 1)  MGI  Alliance
more info ...
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01181,421,672 - 81,444,466 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01184,502,772 - 84,541,046 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41180,008,752 - 80,031,601 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11180,066,341 - 80,089,190 (-)NCBI
Celera1176,684,934 - 76,707,727 (-)NCBICelera
Cytogenetic Map11q23NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Kng1
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1359376
Created: 2005-07-29
Species: Rattus norvegicus
Last Modified: 2019-04-12
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.